The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
0-15, 0-24, 0-30 or 0-48 hours post fertilization (hpf) or 15-120, 24-120, 30-120<br />
and 48-120hpf. Embryos treated until 15hpf or treated after 30hpf did not exhibit<br />
a significant increase in lesions, while embryos treated between 15-30hpf had a significant<br />
increase in MTBE specific vascular lesions (p≤0.05). We hypothesized that<br />
MTBE disrupts the regulation <strong>of</strong> genes in the vascular endothelial growth factor<br />
(VEGF) pathway. <strong>The</strong> effect <strong>of</strong> 5mM MTBE on VEGF associated genes was analyzed<br />
by qPCR at 24h, within the critical period. MTBE significantly (p≤0.05) decreased<br />
expression <strong>of</strong> VEGF-a and -c by 40 and 70% respectively, by had no effect<br />
on VEGF receptor-2 or HIF1-α. Expression <strong>of</strong> Wnt3a, VE-Cadherin5 and βactin<br />
were significantly decreased, while MMP-2 and -9 were not. To further understand<br />
the effect <strong>of</strong> MTBE on zebrafish development at time course analysis <strong>of</strong> global gene<br />
expression patterns was conducted using the Zebrafish Affymetrix GeneChip.<br />
Embryos were exposed to 6.25μM, 0.625mM or 5mM from 0-15, 0-24 or 0-<br />
30hpf. Preliminary evaluation <strong>of</strong> the data show the maximal number <strong>of</strong> genes with<br />
a greater than 2 fold-change occurred at 24hpf for all treatments. <strong>The</strong> least number<br />
<strong>of</strong> gene changes occurred at 30hpf. Taken together, these data suggest that vascular<br />
lesions observed with MTBE exposure develop as a result <strong>of</strong> disruption <strong>of</strong> genes expressed<br />
in the first 24h <strong>of</strong> development despite the fact that lesions are first apparent<br />
at 48hpf. <strong>The</strong>se studies demonstrate critical periods in zebrafish vascular development<br />
and identify pathways sensitive to cardiovascular toxicants. Training Grant<br />
#ES07148 Center Grant #ES05022<br />
2549 EFFECT OF TRIAZINES ON TESTOSTERONE<br />
BIOSYNTHESIS IN BLTK1 MURINE LEYDIG TUMOR<br />
CELLS.<br />
A. L. Forgacs 1 , Q. Ding 1 , I. T. Huhtaniemi 2 , N. A. Rahman 2 and T. R.<br />
Zacharewski 1 . 1 Michigan State University, East Lansing, MI and 2 University <strong>of</strong><br />
Turku, Turku, Finland.<br />
Atrazine (ATR), Simazine (SIM), and Propazine (PPZ) are equipotent triazine herbicides<br />
that have been implicated in the etiology <strong>of</strong> testicular dysgenesis by altering<br />
steroidogenesis. To further investigate their effects on testosterone biosynthesis,<br />
ATR, SIM, and PPZ were examined in BLTK1 cells, a novel murine Leydig cell line<br />
(BLT-1 cells, clone K1) that possess an intact steroidogenic pathway producing low<br />
basal levels <strong>of</strong> testosterone (T), which can be induced by recombinant human<br />
chorionic gonadotropin (rhCG). ATR, SIM and PPZ (1, 3, 10, 30, 100, 300 and<br />
600 μM) elicited dose-dependent increases in progesterone (P) and T levels up to<br />
4-fold relative to DMSO at 24 hrs as determined by ELISA. Temporal analysis (300<br />
μM at 1, 2, 4, 8, 12, 24 or 48 h) elicited comparable P and T pr<strong>of</strong>iles by all three<br />
triazines (ATR > PRO >> SIM) that were similar to the P and T pr<strong>of</strong>iles induced by<br />
rhCG. ATR elicited time- and dose-dependent induction <strong>of</strong> Star and Hsd17b3<br />
mRNA levels while Hsd3b1, Cyp17a1 and Srd5a1 mRNA expression was repressed.<br />
PPZ elicited similar, albeit weaker, gene expression effects while SIM had<br />
minimal effects on steroidogenic gene expression. <strong>The</strong>se results indicate that triazines<br />
alter P and T levels by regulating gene expression pr<strong>of</strong>iles <strong>of</strong> specific steroidogenic<br />
enzymes.<br />
2550 IMPROVEMENTS AND LIMITATIONS OF THE BOVINE<br />
CORNEAL OPACITY AND PERMEABILITY TEST (BCOP,<br />
OECD TEST GUIDELINE 437) IN ROUTINE TESTING<br />
FOR SEVERE OCULAR IRRITANTS.<br />
H. Raabe 3 , A. Schrage 1 , R. Curren 3 , K. Norman 3 , S. N. Kolle 2 , M. Rey-<br />
Moreno 2 , B. van Ravenzwaay 2 and R. Landsiedel 2 . 1 Product Safety, BASF SE,<br />
Ludwigshafen, Germany, 2 Experimental <strong>Toxicology</strong> and Ecology, BASF SE,<br />
Ludwigshafen, Germany and 3 Institute for in vitro Sciences, Inc., Gaithersburg, MD.<br />
Data on eye irritation are generally needed for hazard identification <strong>of</strong> chemicals.<br />
Since the bovine corneal opacity and permeability (BCOP) test has been accepted<br />
by many regulatory agencies for the identification <strong>of</strong> corrosive and severe ocular irritants<br />
since September 2009 (OECD Test Guideline 437), we evaluated this alternative<br />
method using a broad variety <strong>of</strong> chemicals and formulations. Ten reference<br />
standards recommended in the TG437 and 21 substances (including historical false<br />
negatives [FN] and false positives [FP]) with published BCOP and in vivo data<br />
were tested in two labs (BASF and IIVS). Our results matched the published in<br />
vitro data very well, the concordance was 77% (24/31) with FN and FP rates <strong>of</strong><br />
20% (2/10) and 24% (5/21). However, one <strong>of</strong> the solid test substances, Dibenzoyl-<br />
L-tartaric acid, had a high variability in both labs resulting in false negative (FN)<br />
classifications in about half <strong>of</strong> the BCOP assays performed (n=8). Additionally as<br />
suggested by the guideline, we used histopathological evaluation <strong>of</strong> cross sections <strong>of</strong><br />
treated corneas to identify false FN. This endpoint corrected the classification <strong>of</strong><br />
some FN, but increased the number <strong>of</strong> false positives at the same time. Thus it did<br />
not increase <strong>of</strong> the overall predictivity. In parallel, we compared the opacitometer<br />
546 SOT 2011 ANNUAL MEETING<br />
which was originally used in the development <strong>of</strong> the BCOP in the 1980s to a new<br />
opacitometer model with certified components, electronic data processing and calibration<br />
standards (glass filters). <strong>The</strong> data obtained with the new instrument correlated<br />
almost perfectly with the traditionally machine. Regardless <strong>of</strong> the utilized<br />
equipment, we recommend the use <strong>of</strong> calibration filters for stability, reproducibility<br />
and comparability <strong>of</strong> BCOP results from different laboratories.<br />
2551 ECVAM PREVALIDATION STUDY ON SKIN<br />
SENSITISATION ALTERNATIVES: UPDATE ON<br />
PROGRESS.<br />
A. Angers-Loustau 1 , D. Basketter 2 , P. Aeby 3 , S. Aiba 4 , N. Alépée 8 , T. Ashikaga 5 ,<br />
T. Cole 1 , A. Compagnoni 1 , G. Gerberick 6 , S. H<strong>of</strong>fmann 7 , J. Ovigne 8 , J.<br />
Richmond 9 , H. Sakaguchi 10 and S. Casati 1 . 1 European Commission (Joint Research<br />
Centre), Ispra, Italy, 2 DABMEB Consultancy Ltd., Sharnbrook, Bedfordshire, United<br />
Kingdom, 3 Colipa, Skin Tolerance Task Force, Brussels, Belgium, 4 Tohoku University<br />
Graduate School <strong>of</strong> Medicine, Sendai, Japan, 5 Shiseido Quality Assessment Center,<br />
Yokohama, Japan, 6 Procter & Gamble, Cincinnati, OH, 7 Seh Consulting & Services,<br />
Koln, Germany, 8 L’Oréal Research, Aulnay-sous-Bois, France, 9 Home Office,<br />
Dundee, United Kingdom and 10 Kao Corporation Safety Science Research<br />
Laboratories, Tochigi, Japan.<br />
Recent progress with in vitro assays in skin sensitization toxicology has resulted in<br />
the development <strong>of</strong> test methods which could make a valuable contribution to the<br />
replacement <strong>of</strong> the existing animal tests. ECVAM is currently evaluating three approaches:<br />
the Direct Peptide Reactivity Assay (DPRA), the Myeloid U937 Skin<br />
Sensitization Test (MUSST) and the human Cell Line Activation Test (h-CLAT) in<br />
a prevalidation study conducted in liaison with JaCVAM and ICCVAM. <strong>The</strong> main<br />
purpose <strong>of</strong> the study is to assess the robustness and reliability (within- and betweenlaboratory<br />
reproducibility) <strong>of</strong> the test methods. To this end, they are challenged<br />
with a set <strong>of</strong> 24 coded chemicals in three laboratories each. Results generated in this<br />
study will allow exploring the possible contribution <strong>of</strong> these tests to the prediction<br />
<strong>of</strong> skin sensitisers and their potency. An overview <strong>of</strong> the challenges and conclusions<br />
<strong>of</strong> the Transferability phase will be presented, as well as additional preliminary results<br />
from the testing phase with coded chemicals. In the case <strong>of</strong> the DPRA, the experimental<br />
part will be finalized and the results presented.<br />
Disclaimer: <strong>The</strong> views expressed in this poster are purely those <strong>of</strong> the authors, and<br />
should not be regarded as an <strong>of</strong>ficial position <strong>of</strong> the European Commission.<br />
2552 LEYDIG CELLS RESPONSES TO STIMULATION WITH<br />
LUTEINIZING HORMONE IN CULTURES FROM RATS<br />
OF DIFFERENT AGE.<br />
P. Balbuena, J. L. Campbell, R. Clewell and H. J. Clewell. <strong>The</strong> Hamner Institutes<br />
<strong>of</strong> Health Sciences, Research Triangle Park, NC.<br />
Leydig cells, which synthesize and secrete testosterone, are essential in the development<br />
and maintenance <strong>of</strong> male phenotype and reproductive capacity. Most <strong>of</strong> the<br />
information available in the literature on Leydig cells originated from evaluation <strong>of</strong><br />
whole animals, intact testes, or tumor-derived cell lines. However, alterations in cellular<br />
function associated with immortalization limits the use <strong>of</strong> cell lines for studying<br />
normal function or chemical disruption <strong>of</strong> the Leydig cell itself. A viable system<br />
based on primary Leydig cell cultures would present a great advantage in elucidating<br />
mechanisms <strong>of</strong> action for compounds affecting Leydig cells steroidogenesis.<br />
Primary cultures <strong>of</strong> Leydig cells were established from testes <strong>of</strong> 1, 3, and 5 month<br />
old Sprague Dawley rats. Passages <strong>of</strong> these cultures were performed until cells<br />
reached senescence. Cells were then tested for production <strong>of</strong> testosterone in response<br />
to Luteinizing hormone (LH) at 2, 4, 8, 16, and 24 hr. Since adult Leydig<br />
cells require LH stimulation to produce testosterone, LH induction and measurements<br />
<strong>of</strong> hormone production allowed us to assess variability due to time <strong>of</strong> exposure,<br />
passage <strong>of</strong> cells, and age <strong>of</strong> the primary cells in culture.<br />
LH induced testosterone concentrations increased over time, with maximum levels<br />
8-fold that <strong>of</strong> the control at 16 hr. for all ages. LH-induction <strong>of</strong> testosterone in the<br />
1 and 3 months old rat cells reached 5-7 ng/ml, but in the 5 months old rat cells the<br />
levels were 0.05 ng/ml. Cells from 3 month old rats were viable up to 5 passages.,<br />
although testosterone production decreased at passage 3. Passages <strong>of</strong> cells from 5<br />
month old rats were not viable. This system shows considerable potential for the<br />
study <strong>of</strong> age dependent differences in normal Leydig cell function without the additional<br />
complications inherent in an in vivo system. Furthermore, the ability to<br />
maintain testosterone production in passaged cells presents an opportunity for<br />
long-term study <strong>of</strong> molecular mechanisms <strong>of</strong> compounds associated with Leydig<br />
cell abnormal function.